Amdocs Limited $DOX Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA trimmed its holdings in Amdocs Limited (NASDAQ:DOX) by 3.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 439,935 shares of the technology company’s stock after selling 16,018 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Amdocs were worth $36,097,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Harbor Capital Advisors Inc. purchased a new stake in shares of Amdocs in the third quarter worth about $26,000. Rossby Financial LCC purchased a new position in Amdocs during the second quarter valued at approximately $41,000. Caitong International Asset Management Co. Ltd lifted its holdings in Amdocs by 537.8% in the second quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock valued at $43,000 after acquiring an additional 398 shares during the period. Quent Capital LLC purchased a new stake in Amdocs in the 3rd quarter worth approximately $46,000. Finally, Neo Ivy Capital Management purchased a new stake in Amdocs in the 2nd quarter worth approximately $54,000. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Wall Street Analysts Forecast Growth

DOX has been the subject of several recent research reports. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Stifel Nicolaus cut their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Bank of America decreased their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Finally, Wolfe Research restated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $97.00.

Amdocs Stock Performance

DOX opened at $82.84 on Thursday. The firm’s fifty day simple moving average is $79.42 and its two-hundred day simple moving average is $83.22. Amdocs Limited has a 52-week low of $74.32 and a 52-week high of $95.41. The company has a market cap of $8.94 billion, a price-to-earnings ratio of 16.40, a PEG ratio of 1.39 and a beta of 0.40. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.23.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a yield of 2.5%. The ex-dividend date is Wednesday, December 31st. Amdocs’s payout ratio is presently 41.78%.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.